What is Kindbody?
Founded in 2018 and headquartered in New York City, Kindbody is redefining women's healthcare by integrating advanced technology with accessible, modern clinics. The company offers a comprehensive suite of services including fertility treatments, gynecology, and wellness programs. By leveraging a tech-forward approach, Kindbody aims to provide a more personalized and efficient healthcare experience, positioning itself as a leader in the rapidly evolving digital health landscape. Its strategic focus on both service delivery and technological integration highlights its commitment to improving patient outcomes and accessibility.
How much funding has Kindbody raised?
Kindbody has raised a total of $234M across 5 funding rounds:
Series A
$15M
Series B
$32M
Series C
$62M
Private Equity
$100M
Private Equity
$25M
Series A (2019): $15M, investors not publicly disclosed
Series B (2020): $32M led by GV, Rock Springs Capital, RRE, Claritas Capital, Freemark Capital, Goodgrower, and Perceptive Advisors
Series C (2021): $62M supported by Bramalea Partners, Theresa Sexton, Eldridge Industries, and Monashee Investment Management
Private Equity (2023): $100M featuring Perceptive Advisors
Private Equity (2023): $25M backed by JPMorgan Chase
Key Investors in Kindbody
Eldridge Industries
Eldridge Industries is a diversified asset management and insurance holding company that manages substantial capital across multiple investment and insurance platforms, focusing on sophisticated investment strategies and providing capital solutions across various credit markets.
Monashee Investment Management
Monashee Investment Management, founded in 2011 and based in Boston, Massachusetts, is a financial services company specializing in providing investment advice and capital solutions.
GV
GV is a venture capital firm that invests across multiple stages and sectors, focusing on enterprise solutions, life sciences, consumer products, and frontier technology innovations, providing financial backing to promising startups and growth-stage businesses.
What's next for Kindbody?
The substantial enterprise-level backing and recent strategic investment indicate Kindbody is poised for significant scaling and market penetration. This capital infusion is likely to support the expansion of its clinic footprint, enhancement of its proprietary technology platform, and further development of its service offerings. Kindbody's trajectory suggests a move towards solidifying its position as a dominant player in the women's health and fertility market, potentially exploring new service lines or geographic expansions to capitalize on growing demand for integrated healthcare solutions.
See full Kindbody company page
